Literature DB >> 6338153

Characterization of a non-syncytiogenic autonomously replicating variant of measles virus.

K C McCullough.   

Abstract

A variant, derived from both measles and subacute sclerosing panencephalitis virus preparations, incapable of producing intercellular fusion or syncytia typical of measles virus infections is described. This non-syncytiogenic (N-S) virus was easily detected using immunofluorescence, was genetically stable and replicated autonomously. The variant was defective in the production of both infectious virus and haemagglutinin in Vero and Hep2 cells. Persistent infections in Hep2 cells were readily established without the cooperation of defective interfering particles or temperature-sensitive mutants, although interferon could be detected. It is possible that such N-S variants may be involved with the regulation of persistent infections by measles virus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338153     DOI: 10.1099/0022-1317-64-3-749

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Mutations in the stalk region of the measles virus hemagglutinin inhibit syncytium formation but not virus entry.

Authors:  Matthew K Ennis; Chunling Hu; Shruthi K Naik; Louay K Hallak; Kah Whye Peng; Stephen J Russell; David Dingli
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

2.  Human metapneumovirus establishes persistent infection in the lungs of mice and is reactivated by glucocorticoid treatment.

Authors:  Yuru Liu; Debra L Haas; Spencer Poore; Sanjin Isakovic; Michelle Gahan; Suresh Mahalingam; Zhen F Fu; Ralph A Tripp
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

3.  Cell-cell fusion induced by measles virus amplifies the type I interferon response.

Authors:  F Herschke; S Plumet; T Duhen; O Azocar; J Druelle; D Laine; T F Wild; C Rabourdin-Combe; D Gerlier; H Valentin
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.